APA (7th ed.) Citation

M, X., F, V., M, B., GM, B., A, I., Y, B., . . . V, R. (2015). NZ51, a ring-expanded nucleoside analog, inhibits motility and viability of breast cancer cells by targeting the RNA helicase DDX3. Oncotarget, 6(30), 29901. https://doi.org/10.18632/oncotarget.4898

Chicago Style (17th ed.) Citation

M, Xie, et al. "NZ51, a Ring-expanded Nucleoside Analog, Inhibits Motility and Viability of Breast Cancer Cells by Targeting the RNA Helicase DDX3." Oncotarget 6, no. 30 (2015): 29901. https://doi.org/10.18632/oncotarget.4898.

MLA (9th ed.) Citation

M, Xie, et al. "NZ51, a Ring-expanded Nucleoside Analog, Inhibits Motility and Viability of Breast Cancer Cells by Targeting the RNA Helicase DDX3." Oncotarget, vol. 6, no. 30, 2015, p. 29901, https://doi.org/10.18632/oncotarget.4898.